Stacker 2 Capsules Ingredients, Side Effects and Drug Interactions
by Stacker 2 Dietary Supplement Capsule Other Combinations
UPC 3 58286 94004 7 Match it to the barcode on your bottle
Summary: The HelloPharmacist Team’s Take
- Form
- Capsule
- Serving Size
- 1 Capsule
- Container Holds
- 4 Capsules
What’s in it, whether it interacts with your drugs, its side effects, whether it works, and what our pharmacists would want you to know before you start it.
- What is Stacker 2 Capsules?A supplement from Stacker 2 with eight active ingredients, in capsule form.
- Active Ingredients Kola NutYerba Mate extractCassia Mimosoides ExtractWhite WillowCaffeine 200 mgGreen TeaGuggulsteroneGymnema Eight active ingredients. Each one can interact with drugs or cause side effects on its own, so we check every one. The full Supplement Facts
- Drug Interactions 1,348 drugs have a documented interaction with this supplement; the most serious is rated major. Of those, 901 are single drugs and 447 are combination products (two or more drugs in one), each listed under its own name. Based on the 5 of its 8 ingredients we could check. Ask your pharmacist first if you take a drug in any of these categories, the most serious of the 63 on record:
- EphedrineMajor · 8 drugs
- Atorvastatin (Lipitor)Major · 3 drugs
- Nadolol (Corgard)Major · 2 drugs
- Moderate · 372 drugs
- Possible Side EffectsHeadache 3 ingredientsNervousness 3 ingredientsFast heartbeat 2 ingredientsFeeling jittery 2 ingredientsJitteriness 2 ingredientsNausea 2 ingredients +14 moreCombined from five of its eight active ingredients. Not studied in this exact product.
- Well documented Why
Does Stacker 2 Capsules work?
What It Is Marketed For
Fat burning and weight loss support
From the claims on the product’s label.
The Closest Use the Research Grades
Caffeine
Some studies support it, but the evidence isn’t conclusive.
Its ingredients have stronger research for other uses:
- Caffeine
- Mental alertness Caffeine
- Green Tea
- Cardiovascular disease (CVD) Green Tea
- Caffeine
These grades are for each ingredient, not this exact product, and never a promise it will work for you.
And 2 more graded uses, in what the research says- Low Why
- AllergensNone of its ingredient names point to a major food allergen, and the label text we have carries no allergen statement
- Barcode (UPC)3 58286 94004 7Match it to the barcode on your bottle to be sure this is your product. Not your product? Search for it here
Who Might Consider It
- People looking for fat burning and weight loss support, which is what it is marketed for. The closest use the research grades is obesity, rated Possibly Effective.
- People who want it for athletic performance, mental alertness, hyperlipidemia, cardiovascular disease (CVD) or another graded use: the other uses with research behind them. See each grade
- Stacker 2 may appeal to adults looking for a caffeine-based stimulant product, but its effects and interactions depend heavily on the caffeine content.
Who Should Be Careful
- People with heart problems, high blood pressure, anxiety, seizure disorders, diabetes, or those taking blood-sugar-lowering medicines should be especially careful.
- If you are pregnant, breastfeeding, or take any prescription medication, please talk it over with your own doctor or pharmacist before starting.
More Before You Take It Show both answersHide Pregnancy and Breastfeeding The Label’s Directions
-
Pregnant or breastfeeding?
- Pregnancy Cola Nut
- ! When caffeine, a constituent of cola nut, is used orally in amounts over 300 mg daily.
- Breastfeeding Cola Nut
- ! When used orally in large amounts.
- Pregnancy Yerba Mate
- ! When used orally.
- Breastfeeding Yerba Mate
- ! When used orally.
- Pregnancy Caffeine
- ! When used orally in amounts over 300 mg daily.
- Breastfeeding Caffeine
- ! When used orally in large amounts.
-
How does the label say to take it?
“SUGGESTED USE: ONE CAPSULE AFTER MEALS.”
The maker’s words. Your pharmacist or doctor may advise differently.
Everything the label says
From the label dated Mar 25, 2013: 5 of its 8 active ingredients were checked against our records; the other three are not in them yet. A summary of what is known, not a grade or a test of the product. How these ratings are computed
Ask Anything About This Supplement
Name a drug you take, or ask about side effects, ingredients or pregnancy.
AI answers come from this label and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI
Ask the Pharmacist
A licensed pharmacist will answer your question by email — free, as soon as they can.
Got it — thank you!
A licensed pharmacist will answer as soon as they can. Keep an eye on your email (worth checking spam, just in case).
What’s Inside Stacker 2 Capsules
Eight Active Ingredients, Each Checked on Its Own
A supplement is often several ingredients in one bottle, and each one can interact with drugs or cause side effects on its own. We check every one of them against our records.
- Kola NutDrug interactions on record, most serious: Moderate
- Yerba Mate extractDrug interactions on record, most serious: Major
- Cassia Mimosoides ExtractNot in our interaction records yet
- White WillowNot in our interaction records yet
- CaffeineDrug interactions on record, most serious: Major
- Green TeaDrug interactions on record, most serious: Major
- GuggulsteroneNot in our interaction records yet
- GymnemaDrug interactions on record, most serious: Moderate
The label gives an exact amount for 3 of its 8 active ingredients. The other five are inside two proprietary blends, and the label gives one total for each, not how much of each ingredient is in it.
- 3 state an exact amount
- 5 have no amount of their own
- Proprietary Blend 198 mg in total · 4 ingredients, 3 with no amount of their own
- Tri-Gugglyptoid3 Complex(TM) 25 mg in total · 3 ingredients, 2 with no amount of their own
This rates what the label tells you, not the quality of the product.
Supplement Facts
| Amount Per Serving | % Daily Value | |
|---|---|---|
| Proprietary Blend | 198 mg | † |
| Kola Nut | † | |
| 3mg caffeine | 3 mg | † |
| Yerba Mate extract | † | |
| Cassia Mimosoides Extract | † | |
| White Willow | † | |
| Caffeine | 200 mg | † |
| Tri-Gugglyptoid3 Complex(TM) | 25 mg | † |
| Green Tea | † | |
| <1mg caffeine | 1 mg | † |
| Guggulsterone | † | |
| Gymnema | † | |
Other ingredients: Dextrose, Gelatin, Stearic Acid, Magnesium Stearate, Titanium Dioxide, FD&C YELLOW #5, FD&C BLUE #1, FD&C RED #3, FD&C YELLOW #6
† Daily Value not established.
Daily Values for adults and children 4 or more years of age.
As the label prints it, from the NIH Dietary Supplement Label Database.
Each Ingredient and Its Drug Interactions
Tap one for more about it and its full guide. A drug can interact with this supplement through any one of them.
The active ingredients in Stacker 2 are caffeine, gymnema, and yerba mate extract, along with several blends and extracts such as green tea, kola nut, and a proprietary blend.
- Gymnema is a plant ingredient that is linked to diabetes, obesity, and blood sugar research.
-
Proprietary Blend 198 mg Four ingredients inside it, each checked on its own
- Kola Nut 655 drugs
- Yerba Mate extract 1,087 drugs
- Cassia Mimosoides Extract
- White Willow
-
Caffeine 200 mg Caffeine appears in several entries, including a 3mg caffeine line and a less-than-1mg caffeine line, and it is a stimulant. Yerba mate extract is a plant ingredient that also contains caffeine. Interacts with 655 drugs
Form on the label: Caffeine Anhydrous
Caffeine is a natural stimulant found in coffee, tea, and many other plants and products.
- In moderate amounts it can boost alertness and reduce tiredness for most healthy adults, but too much can cause jitteriness, a racing heart, and sleep problems.
- Pregnant women and people with heart conditions or anxiety should be especially careful and check with a doctor or pharmacist.
The full Caffeine guide: uses, dosage and safety Every Caffeine drug interaction
Other Ingredients (Inactive)
The capsule or tablet itself, fillers, coatings and flavors. Not part of the drug interaction check; the allergen check below reads them.
- Dextrose
- Gelatin
- Stearic Acid
- Magnesium Stearate
- Titanium Dioxide
- FD&C YELLOW #5
- FD&C BLUE #1
- FD&C RED #3
- FD&C YELLOW #6
Allergens in Stacker 2 Capsules
None of its ingredient names point to a major food allergen, and the label text we have carries no allergen statement.
Named on this label
- Gelatin (animal-derived)In the ingredients: Gelatin
Not named in the ingredients
- Milk
- Egg
- Fish
- Shellfish
- Tree nuts
- Peanuts
- Wheat or other gluten grains
- Soy
- Sesame
From the label text and ingredient names on file; we do not test products. With a serious allergy, check your bottle and ask the maker or your pharmacist.
What the Label Says
The maker’s own words, from the label. We do not verify or endorse them.
- Brand IP Statement(s)
-
“(C)2005 NVE Pharmaceuticals. All Rights Reserved. The appearance of product and packaging are trademarks of NVE Pharmaceuticals. All Rights Reserved.”
“DIET ENERGY SPECIALISTS(TM)”
“MANUFACTURERS OF THE WORLD'S STRONGEST FAT BURNER(TM)”
- FDA Statement of Identity
-
“HERBAL DIETARY & ENERGY SUPPLEMENT”
- General statements
-
“D012010 LOT# 94-2404”
- Seals and symbols
-
“MADE IN USA”
The Stacker 2 Capsules Label on File
The label scan on file at the NIH Dietary Supplement Label Database, dated March 2013. Always read the label on the bottle you have.
Product Facts
Is this label outdated? Report a formula or label change and our pharmacy team will review it.
Stacker 2 Capsules Side Effects
Why this rating?
We look for three kinds of safety information on each ingredient: side effects reported in studies, a pregnancy and breastfeeding rating, and a safety write-up from our pharmacy team. All three are on file for each of the five ingredients we could check.
So this rates how much is known, not whether Stacker 2 Capsules is right for you.
Reported with five of its ingredients
- Most often
- Headache, nervousness, fast heartbeat, feeling jittery, jitteriness and nausea
- !Rare but serious
- Increased risk of oral cancer, hyperglycemia and ketosis See details
HelloPharmacist Team Summary: Stacker 2 Capsules Side Effects
You are most likely to notice jitteriness, nervousness or anxiety, a racing or pounding heartbeat, and trouble sleeping, which mostly come from the caffeine and yerba mate.
- Upset stomach or heartburn is also commonly reported, and gymnema can cause a temporary loss of the ability to taste sweetness.
- Serious effects are uncommon, but rare cases of stroke have been reported with caffeine, and a rare case of liver inflammation has been reported with gymnema tea, so call your doctor right away if you notice yellowing skin, unusual weakness, or severe symptoms.
- Because lightheadedness has been reported, see how Stacker 2 affects you before driving.
- Please talk with your own doctor or pharmacist before starting if you have heart problems, high blood pressure, anxiety, diabetes, or seizure disorders, or if you are pregnant or breastfeeding.
Side Effects, Ingredient by Ingredient
A supplement’s side effects come from its ingredients. Here is what is reported with each one.
Cola Nut
Most reported
- Jitteriness
- Restlessness
- Nervousness
- Fast or pounding heartbeat
Yerba Mate
Most reported
- Jitteriness
- Nervousness
- Fast heartbeat
- Headache
Caffeine
Most reported
- Feeling jittery, nervous, or anxious
- Racing or pounding heartbeat
- Trouble sleeping
- Upset stomach or heartburn
Green Tea
Most reported
- Trouble sleeping or feeling jittery
- Nervousness or anxiety
- Upset stomach or nausea, especially on an empty stomach
- Headache
Gymnema
Most reported
- Stomach upset, nausea, or gas
- Headache or lightheadedness
- A temporary loss of the ability to taste sweetness
Stacker 2 Capsules Warnings: Who Should Be Careful
Stacker 2 Capsules has eight active ingredients, and each can carry warnings of its own. We checked the five in our ingredient guides, and each warning below names the ingredient it comes from. Cassia Mimosoides Extract, White Willow and Guggulsterone are not in our guides yet, so ask your pharmacist about them. If any of these apply to you, talk to your doctor or pharmacist before you start it.
- Cola Nut3 warnings below
- Yerba Mate3 warnings below
- Caffeine2 warnings below
- Green Tea3 warnings below
- Gymnema3 warnings below
- Cassia Mimosoides ExtractNot in our guides yet
- White WillowNot in our guides yet
- GuggulsteroneNot in our guides yet
-
Bleeding Problems or Surgery
- Green TeaThe same goes for people with bleeding disorders or those preparing for surgery.
-
Diabetes or Low Blood Sugar
- GymnemaBecause gymnema can lower blood sugar, people with diabetes or those taking blood-sugar-lowering medicines should use it carefully and monitor for signs of low blood sugar, such as shakiness, sweating, or dizziness.
-
Blood Pressure
- Cola NutPeople with heart problems, high blood pressure, irregular heartbeat, anxiety, sleep problems, or stomach ulcers should be cautious or avoid it.
- Yerba MateBecause it contains caffeine, people who are sensitive to stimulants, who have heart problems, high blood pressure, anxiety, or trouble sleeping should be cautious.
- CaffeineBe cautious if you: have heart problems, high blood pressure, an irregular heartbeat, anxiety, panic attacks, trouble sleeping, stomach ulcers, or seizure disorders.
-
Liver Disease
- Green TeaPeople with liver disease should be especially careful and check with a healthcare provider first.
-
Heart Conditions
- Green TeaBecause green tea contains caffeine, people who are sensitive to caffeine, have heart rhythm problems, anxiety, or trouble sleeping should be cautious.
-
Children
- Cola NutChildren and people sensitive to caffeine should also avoid it.
- Yerba MateChildren should generally avoid caffeinated mate.
- CaffeineChildren and teens should limit caffeine.
- GymnemaChildren should not use it unless directed by a healthcare provider.
-
Other Cautions
- Yerba MateAlways talk to your pharmacist or doctor before using it regularly, especially if you have a medical condition.
-
What the Label Warns
- “DO NOT USE IF YOU ARE PREGNANT OR NURSING.”
- “IMPORTANT: READ DIRECTIONS ON REVERSE SIDE BEFORE USE.”
- “NOT RECOMMENDED FOR USE BY MINORS KEEP OUT OF REACH OF CHILDREN.”
- “DO NOT EXCEED THREE DAILY.”
- “WARNING: NOT RECOMMENDED FOR USE BY MINORS.”
- “DO NOT EXCEED SUGGESTED SERVING. INDIVIDUALS WHO CONSUME CAFFEINE WITH THIS PRODUCT MAY EXPERIENCE SERIOUS ADVERSE HEALTH EFFECTS. INDIVIDUALS WHO ARE SENSITIVE TO THE EFFECTS OF CAFFEINE SHOULD CONSULT A LICENSED HEALTH CARE PROFESSIONAL BEFORE CONSUMING THIS PRODUCT. IN CASE OF ACCIDENTAL OVERDOSE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY. AVOID ALCOHOL WHILE TAKING THIS PRODUCT. DO NOT EXCEED RECOMMENDED SERVING. EXCEEDING RECOMMENDED SERVING MAY CAUSE SERIOUS ADVERSE HEALTH EFFECTS, INCLUDING HEART ATTACK AND STROKE. DISCONTINUE USE AND CALL A PHYSICIAN OR LICENSED QUALIFIED HEALTH CARE PROFESSIONAL IMMEDIATELY IF YOU EXPERIENCE RAPID HEARTBEAT, DIZZINESS, SEVERE HEADACHE, SHORTNESS OF BREATH OR OTHER SIMILAR SYMPTOMS. IMPROPER USE OF THIS PRODUCT MAY BE HAZARDOUS TO A PERSON'S HEALTH. EXCEEDING RECOMMENDED SERVING WILL NOT IMPROVE RESULTS.”
The maker’s wording, from the product label.
-
Pregnant or Breastfeeding
Each ingredient’s rating for pregnancy and for breastfeeding, and what it covers.
Pregnancy
-
When used orally in amounts found in foods.
Due to the caffeine content of cola nut, pregnant patients should closely monitor their intake to ensure moderate consumption.
10 more points on this rating
- Fetal blood concentrations of caffeine approximate maternal concentrations.
- The use of caffeine during pregnancy is controversial; however, moderate consumption has not been associated with clinically important adverse fetal effects.
- In some studies, consuming amounts over 200 mg daily is associated with a significantly increased risk of miscarriage.
- This increased risk may be most likely to occur in those with genotypes that confer a slow rate of caffeine metabolism.
- According to a review by Health Canada, and a subsequent large meta-analysis conducted in the US, most healthy pregnant patients can safely consume caffeine in doses up to 300 mg daily without an increased risk of spontaneous abortion, stillbirth, preterm birth, fetal growth retardation, or congenital malformations.
- Advise keeping caffeine consumption below 300 mg daily.
- This is similar to the amount of caffeine in about 3 cups of coffee or tea.
- Keep in mind that only the amount of ADDED caffeine must be stated on product labels.
- The amount of caffeine found in ingredients such as cola nut, which naturally contains caffeine, does not need to be provided.
- This can make it difficult to determine the total amount of caffeine in a given product.
-
When caffeine, a constituent of cola nut, is used orally in amounts over 300 mg daily.
Caffeine crosses the placenta, producing fetal blood concentrations similar to maternal levels.
9 more points on this rating
- Advise keeping caffeine consumption from all sources below 300 mg daily.
- High doses of caffeine throughout pregnancy have resulted in symptoms of caffeine withdrawal in newborn infants.
- High doses of caffeine have also been associated with spontaneous abortion, premature delivery, and low birth weight.
- Keep in mind that only the amount of added caffeine must be stated on product labels.
- The amount of caffeine found in ingredients such as cola nut, which naturally contains caffeine, does not need to be provided.
- This can make it difficult to determine the total amount of caffeine in a given product.
- In a study that included 2 large cohorts of mother/infant pairs, the first cohort with a median maternal plasma caffeine level of 168.5 ng/mL (range 29.5-650.5 ng/mL) during pregnancy, suggests birth weights and lengths were lower in the 4th quartile of caffeine intake compared with the 1st.
- By age 7, heights and weights were lower by 1.5 cm and 1.1 kg, respectively.
- In the second cohort of mother/infant pairs with higher maternal pregnancy plasma caffeine levels, median 625.5 ng/mL (range 86.2 to 1994.7 ng/mL), heights at age 8 were 2.2 cm lower, but there was no difference in weights.
Breastfeeding
-
When used orally in amounts found in foods.
Due to the caffeine content of cola nut, caffeine intake should be closely monitored while nursing.
2 more points on this rating
- Breast milk concentrations of caffeine are thought to be approximately 50% of maternal serum concentrations.
- Minimal consumption would likely result in limited exposure to a nursing infant.
-
When used orally in large amounts.
Consumption of cola nut might cause sleep disturbances, irritability, and increased bowel activity in nursing infants due to its caffeine content.
2 more points on this rating
- Large doses or excessive intake of cola nut should be avoided during lactation.
- It is unknown whether potentially carcinogenic constituents of cola nut are transferred via breast milk.
Pregnancy
-
When used orally.
Yerba mate is associated with an increased risk of cancer, including esophageal, kidney, bladder, cervical, prostate, lung, renal cell, and possibly mouth and laryngeal cancer.
9 more points on this rating
- However, teratogenic studies have not been performed.
- Yerba mate also contains caffeine.
- Caffeine crosses the placenta, producing fetal blood concentrations similar to parental levels.
- According to a review by Health Canada, and a subsequent large meta-analysis conducted in the US, most healthy pregnant patients can safely consume caffeine in doses up to 300 mg daily without an increased risk of spontaneous abortion, stillbirth, preterm birth, fetal growth retardation, or congenital malformations.
- It is generally recommended to avoid consuming more than 300 mg of caffeine daily, or around 6-7 cups of yerba mate daily, when pregnant.
- High doses of caffeine throughout pregnancy have resulted in symptoms of caffeine withdrawal in newborn infants.
- Caffeine in doses of greater than 300 mg daily has also been associated with spontaneous abortion, premature delivery, and low birth weight, although one retrospective study found that consuming yerba mate tea during pregnancy was not associated with preterm or small for gestational age births.
- However, this study did not consider the amount of yerba mate or caffeine consumed, only the frequency of consumption.
- Some research has found that intrauterine exposure to even modest amounts of caffeine, based on maternal blood levels during the first trimester, is associated with a shorter stature in children ages 4-8 years.
Breastfeeding
-
When used orally.
Yerba mate is associated with an increased risk of cancer, including esophageal, kidney, bladder, cervical, prostate, lung, renal cell, and possibly mouth and laryngeal cancer.
3 more points on this rating
- Whether carcinogenic constituents of yerba mate are transferred via breast milk is unknown.
- Yerba mate contains caffeine.
- Consumption of yerba mate might cause irritability and increased bowel activity in nursing infants.
Show 3 more ingredients
Pregnancy
-
When used orally in amounts commonly found in foods.
Intakes of caffeine should be monitored during pregnancy.
10 more points on this rating
- Caffeine crosses the human placenta, but is not considered a teratogen.
- Fetal blood and tissue levels are similar to maternal concentrations.
- The use of caffeine during pregnancy is controversial; however, moderate consumption has not been associated with clinically important adverse fetal effects.
- In some studies consuming amounts over 200 mg daily is associated with a significantly increased risk of miscarriage.
- This increased risk seems to occur in those with genotypes that confer a slow rate of caffeine metabolism.
- According to a review by Health Canada, and a subsequent large meta-analysis conducted in the US, up to 300 mg daily can be consumed during pregnancy without an increased risk of spontaneous abortion, stillbirth, preterm birth, fetal growth retardation, or congenital malformations.
- However, observational research in a Norwegian cohort found that caffeine consumption is associated with a 16% increased odds of the baby being born small for gestational age when compared with no consumption.
- The same Norwegian cohort found that low to moderate caffeine consumption during pregnancy is not associated with changes in neurodevelopment in children up to 8 years of age.
- Advise patients to keep caffeine consumption below 300 mg daily during pregnancy.
- This is similar to the amount of caffeine in about 3 cups of coffee or tea.
-
When used orally in amounts over 300 mg daily.
Caffeine crosses the placenta, producing fetal blood concentrations similar to maternal levels.
8 more points on this rating
- Consumption of caffeine in amounts over 300 mg daily is associated with a significantly increased risk of miscarriage in some studies.
- Advise patients to keep caffeine consumption below 300 mg daily during pregnancy.
- This is similar to the amount of caffeine in about 3 cups of coffee or tea.
- Additionally, high doses of caffeine throughout pregnancy have resulted in symptoms of caffeine withdrawal in newborn infants.
- High doses of caffeine have also been associated with spontaneous abortion, premature delivery, and low birth weight.
- In a cohort of mother/infant pairs with a median maternal plasma caffeine level of 168.5 ng/mL (range 29.5-650.5 ng/mL) during pregnancy, birth weights and lengths were lower in the 4th quartile of caffeine intake compared with the 1st.
- By age 7, heights and weights were lower by 1.5 cm and 1.1 kg respectively.
- In another cohort of mother/infant pairs with higher maternal pregnancy plasma caffeine levels, median 625.5 ng/mL (range 86.2 to 1994.7 ng/mL), heights at age 8 were 2.2 cm lower, but there was no difference in weights.
Breastfeeding
-
When used orally in amounts commonly found in foods.
Caffeine intake should be closely monitored while breast-feeding.
During lactation, breast milk concentrations of caffeine are thought to be approximately 50% of serum concentrations and caffeine peaks in breastmilk approximately 1-2 hours after consumption.
-
When used orally in large amounts.
Caffeine is excreted slowly in infants and may accumulate.
Caffeine can cause sleep disturbances, irritability, and increased bowel activity in breast-fed infants exposed to caffeine.
Pregnancy
-
When used orally in moderate amounts.
Due to the caffeine content of green tea, pregnant patients should closely monitor their intake to ensure moderate consumption.
12 more points on this rating
- Fetal blood concentrations of caffeine approximate maternal concentrations.
- The use of caffeine during pregnancy is controversial; however, moderate consumption has not been associated with clinically important adverse fetal effects.
- In some studies consuming amounts over 200 mg daily is associated with a significantly increased risk of miscarriage.
- This increased risk may be most likely to occur in those with genotypes that confer a slow rate of caffeine metabolism.
- According to a review by Health Canada, and a subsequent large meta-analysis conducted in the US, most healthy pregnant patients can safely consume doses up to 300 mg daily without an increased risk of spontaneous abortion, stillbirth, preterm birth, fetal growth retardation, or congenital malformations.
- Advise keeping caffeine consumption below 300 mg daily.
- This is similar to the amount of caffeine in about 6 cups of green tea.
- Keep in mind that only the amount of ADDED caffeine must be stated on product labels.
- The amount of caffeine found in ingredients such as green tea, which naturally contains caffeine, does not need to be provided.
- This can make it difficult to determine the total amount of caffeine in a given product.
- Based on animal models, green tea extract catechins are also transferred to the fetus, but in amounts 50-100 times less than maternal concentrations.
- The potential impact of these catechins on the human fetus is not known, but animal models suggest that the catechins are not teratogenic.
-
When used orally in amounts providing more than 300 mg caffeine daily.
Caffeine from green tea crosses the placenta, producing fetal blood concentrations similar to maternal levels.
16 more points on this rating
- Consumption of caffeine in amounts over 300 mg daily is associated with a significantly increased risk of miscarriage in some studies.
- Advise keeping caffeine consumption from all sources below 300 mg daily.
- This is similar to the amount of caffeine in about 6 cups of green tea.
- High maternal doses of caffeine throughout pregnancy have also resulted in symptoms of caffeine withdrawal in newborn infants.
- High doses of caffeine have also been associated with spontaneous abortion, premature delivery, and low birth weight.
- However, some research has also found that intrauterine exposure to even modest amounts of caffeine, based on maternal blood levels during the first trimester, is associated with a shorter stature in children ages 4-8 years.
- Keep in mind that only the amount of ADDED caffeine must be stated on product labels.
- The amount of caffeine found in ingredients such as green tea, which naturally contains caffeine, does not need to be provided.
- This can make it difficult to determine the total amount of caffeine in a given product.
- There is also concern that consuming large amounts of green tea might have antifolate activity and potentially increase the risk of folic acid deficiency-related birth defects.
- Catechins in green tea inhibit the enzyme dihydrofolate reductase in vitro.
- This enzyme is responsible for converting folic acid to its active form.
- Preliminary evidence suggests that increasing maternal green tea consumption is associated with increased risk of spina bifida.
- Also, evidence from epidemiological research suggests that serum folate levels in pregnant patients with high green tea intake (57.3 mL per 1000 kcal) are decreased compared to participants who consume moderate or low amounts of green tea.
- More evidence is needed to determine the safety of using green tea during pregnancy.
- For now, advise pregnant patients to avoid consuming large quantities of green tea.
Breastfeeding
-
When used orally in moderate amounts.
Due to the caffeine content of green tea, nursing parents should closely monitor caffeine intake.
Breast milk concentrations of caffeine are thought to be approximately 50% of maternal serum concentrations.
-
When used orally in large amounts.
Consumption of green tea might cause irritability and increased bowel activity in nursing infants.
There is insufficient reliable information available about the safety of green tea extracts when applied topically during breast-feeding.
Pregnancy and Breastfeeding The record rates both the same
-
Insufficient reliable information available; avoid using.
Our pharmacy team’s notes
- Yerba MateYerba mate is listed as possibly unsafe in pregnancy, so its safety data advises against it.
- For breastfeeding, caffeine is listed as possibly safe, while yerba mate is possibly unsafe.
Ratings and the words beside them are from the Natural Medicines database, which we license.
-
Rare but Serious Side Effects
-
!
Cola Nut
Orally: Increased risk of oral cancer, gastrointestinal cancer, and West African crystalline retinopathy with long-term use.
-
!
Yerba Mate
Orally: Cancer, hyperglycemia, ketosis, metabolic acidosis, sinus tachycardia. These adverse effects are more common with high doses or long-term use.
-
!
Caffeine
Serious effects are rare but can happen with very high doses.
Caffeine is generally well tolerated in moderate amounts for healthy adults, but our pharmacists say high doses can cause serious side effects.
Orally: Stroke has been reported rarely.
-
!
Green Tea
A rare but serious concern with concentrated green tea extract supplements is liver damage.
Orally: Hepatotoxicity, hypokalemia, and thrombotic thrombocytopenic purpura have been reported rarely.
-
!
Gymnema
Serious side effects appear to be uncommon, but allergic reactions are always possible with any plant product.
When to get help: a serious allergic reaction, with trouble breathing or swelling of the face, lips or throat, needs emergency care: call 911. For any other side effect that worries you, call your doctor or pharmacist.
These reports describe each ingredient, not studies of this exact product. Not medical advice: a side effect you notice after starting a supplement is worth a word with your pharmacist or doctor.
Stacker 2 Capsules Drug Interactions
We checked all eight active ingredients in this supplement against every drug in our records. A drug can interact with it through any one of them. Cassia Mimosoides Extract, White Willow and Guggulsterone are not in our interaction records yet.
A major interaction on record
3 of 3, on a scale from Minor or none to Major.Why this rating?
We rate this by the most serious interaction on record, not by how many there are. For Yerba Mate, Gymnema, Cola Nut, Green Tea and Caffeine, the most serious is rated major, which means the combination is best avoided, or used only under close supervision. Some involve kinds of drugs where a small change can matter, such as blood thinners, diabetes drugs and lithium.
1,349 drugs are on the full list. What matters is whether one you take is on it, so check yours with the interaction checker on this page.
Five of its eight active ingredients have drug interactions on record: Cola Nut, Yerba Mate, Caffeine, Green Tea and Gymnema. We have no interaction records for Cassia Mimosoides Extract, White Willow and Guggulsterone.
- Interacts with
- 655 drugs
- Most serious
- Major
- Moderate interactions include antiseizure and sedative drugs such as phenobarbital, carbamazepine, pentobarbital, valproate, and felbamate, where caffeine may weaken their effects and raise the risk of seizures.
- Moderate interactions also include clozapine, dipyridamole, cimetidine, disulfiram, fluvoxamine, and quinolone antibiotics, which can change how much caffeine or clozapine builds up in your body.
- Interacts with
- 853 drugs
- Most serious
- Moderate
- Gymnema carries Moderate interactions with diabetes medicines, where it may increase the risk of low blood sugar, and with tolbutamide, phenacetin, and drugs cleared by the CYP1A2 and CYP2C9 liver enzymes.
- Interacts with
- 1,294 drugs
- Most serious
- Major
- Most of its records involve Cytochrome P450 3A4 (CYP3A4) Substrates, Hepatotoxic Drugs and P-glycoprotein Substrates.
Show two more ingredients
- Interacts with
- 1,087 drugs
- Most serious
- Major
- Most of its records involve Cytochrome P450 3A4 (CYP3A4) Substrates, Stimulant Drugs and Anticoagulant/Antiplatelet Drugs.
- Interacts with
- 655 drugs
- Most serious
- Moderate
- Most of its records involve Stimulant Drugs, Anticoagulant/Antiplatelet Drugs and Cytochrome P450 1A2 (CYP1A2) Inhibitors.
From the HelloPharmacist Team
Our pharmacy team’s read on the supplement as a whole.
- Stacker 2 capsules can interact with medications, mainly through their caffeine, yerba mate extract, and gymnema content.
- The most serious interaction is a Major one: combining the caffeine or yerba mate with ephedrine, a stimulant, can increase the risk of stimulant side effects, and the evidence suggests it may raise the risk of serious effects such as high blood pressure.
- Several other drug types carry Moderate interactions.
Summarized by the HelloPharmacist pharmacy team from the interaction records below. How it is written How we use AI
Why Stacker 2 Capsules Interacts, Ingredient by Ingredient
A product interacts through its ingredients. Each card: how many drugs, the most serious rating, and the kinds of drugs it affects most (tap a kind for what it means).
The ingredients driving the most interactions
-
Green Tea 1,294 drugs
Most serious: Major58 interaction records on file
The kinds of drugs it affects most
- 645 drugs
- 372 drugs
- 202 drugs
- 172 drugs
Every Green Tea drug interaction, 58 records The Green Tea records cite 219 references, listed in the Green Tea guide.
-
Yerba Mate extract 1,087 drugs
Most serious: Major43 interaction records on file
The kinds of drugs it affects most
- 645 drugs
- 172 drugs
- 122 drugs
- 90 drugs
Every Yerba Mate drug interaction, 43 records The Yerba Mate records cite 124 references, listed in the Yerba Mate guide.
-
Gymnema 853 drugs
Most serious: Moderate6 interaction records on file
The kinds of drugs it affects most
- 645 drugs
- 186 drugs
- 112 drugs
- 86 drugs
Every Gymnema drug interaction, 6 records The Gymnema records cite 12 references, listed in the Gymnema guide.
-
Kola Nut 655 drugs
Most serious: Moderate41 interaction records on file
The kinds of drugs it affects most
- 172 drugs
- 122 drugs
- 90 drugs
- 86 drugs
Every Cola Nut drug interaction, 41 records The Cola Nut records cite 157 references, listed in the Cola Nut guide.
-
Caffeine 655 drugs
Most serious: Major41 interaction records on file
The kinds of drugs it affects most
- 172 drugs
- 122 drugs
- 90 drugs
- 86 drugs
Every Caffeine drug interaction, 41 records The Caffeine records cite 235 references, listed in the Caffeine guide.
The Breakdown by Severity
Each drug counted once, at its most serious rating. Tap a tile to list those drugs.
Find Your Drug
Type a drug or brand name to see whether it is on the list.
- Only drugs with a documented interaction are listed, the most serious first.
- A drug with no known interaction is not listed, but searching its name tells you so.
- Open a drug to see which ingredient is responsible. Of those, 901 are single drugs and 447 are combination products (two or more drugs in one), each listed under its own name.
-
DabrafenibTafinlar Minor
The 3 ingredients responsible:
-
Green Tea Minor Dabrafenib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Dabrafenib interaction -
Gymnema Minor Dabrafenib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Dabrafenib interaction -
Yerba Mate Extract Minor Dabrafenib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Dabrafenib interaction
-
-
BudenosidePulmicort Flexhaler, Pulmicort Turbuhaler Minor
The 3 ingredients responsible:
-
Gymnema Minor Budenoside is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Budenoside interaction -
Green Tea Minor Budenoside is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Budenoside interaction -
Yerba Mate Extract Minor Budenoside is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Budenoside interaction
-
-
AxitinibInlyta Minor
The 3 ingredients responsible:
-
Yerba Mate Extract Minor Axitinib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Axitinib interaction -
Gymnema Minor Axitinib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Axitinib interaction -
Green Tea Minor Axitinib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Axitinib interaction
-
-
ThioridazineMellaril Minor
The 3 ingredients responsible:
-
Green Tea Minor Thioridazine is in the Phenothiazines category.
Theoretically, phenothiazines might increase the levels and adverse effects of caffeine.
The full Green Tea + Thioridazine interaction -
<1mg Caffeine Minor Thioridazine is in the Phenothiazines category.
Theoretically, phenothiazines might increase the levels and adverse effects of caffeine.
The full <1mg Caffeine + Thioridazine interaction -
Kola Nut Minor Thioridazine is in the Phenothiazines category.
Theoretically, phenothiazines might increase the levels and adverse effects of the caffeine in cola nut.
The full Kola Nut + Thioridazine interaction
-
-
MidostaurinRydapt Minor
The 3 ingredients responsible:
-
Gymnema Minor Midostaurin is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Midostaurin interaction -
Yerba Mate Extract Minor Midostaurin is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Midostaurin interaction -
Green Tea Minor Midostaurin is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Midostaurin interaction
-
-
Ado-trastuzumab EmtansineKadcyla Minor
The 3 ingredients responsible:
-
Yerba Mate Extract Minor Ado-trastuzumab Emtansine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Ado-trastuzumab Emtansine interaction -
Green Tea Minor Ado-trastuzumab Emtansine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Ado-trastuzumab Emtansine interaction -
Gymnema Minor Ado-trastuzumab Emtansine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Ado-trastuzumab Emtansine interaction
-
-
AlfuzosinUroxatral Minor
The 3 ingredients responsible:
-
Gymnema Minor Alfuzosin is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Alfuzosin interaction -
Yerba Mate Extract Minor Alfuzosin is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Alfuzosin interaction -
Green Tea Minor Alfuzosin is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Alfuzosin interaction
-
-
VilazodoneViibryd Minor
The 3 ingredients responsible:
-
Gymnema Minor Vilazodone is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Vilazodone interaction -
Green Tea Minor Vilazodone is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Vilazodone interaction -
Yerba Mate Extract Minor Vilazodone is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Vilazodone interaction
-
-
DihydroergotamineDHE-45, Migranal Minor
The 3 ingredients responsible:
-
Green Tea Minor Dihydroergotamine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Dihydroergotamine interaction -
Gymnema Minor Dihydroergotamine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Dihydroergotamine interaction -
Yerba Mate Extract Minor Dihydroergotamine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Dihydroergotamine interaction
-
-
Belumosudil MesylateRezurock Minor
The 3 ingredients responsible:
-
Green Tea Minor Belumosudil Mesylate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Belumosudil Mesylate interaction -
Yerba Mate Extract Minor Belumosudil Mesylate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Belumosudil Mesylate interaction -
Gymnema Minor Belumosudil Mesylate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Belumosudil Mesylate interaction
-
-
DonepezilAricept Minor
The 3 ingredients responsible:
-
Yerba Mate Extract Minor Donepezil is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Donepezil interaction -
Green Tea Minor Donepezil is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Donepezil interaction -
Gymnema Minor Donepezil is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Donepezil interaction
-
-
ZiprasidoneGeodon Minor
The 3 ingredients responsible:
-
Green Tea Minor Ziprasidone is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Ziprasidone interaction -
Gymnema Minor Ziprasidone is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Ziprasidone interaction -
Yerba Mate Extract Minor Ziprasidone is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Ziprasidone interaction
-
-
BuprenorphineBrixadi, Butrans, Sublocade, Subutex Minor
The 3 ingredients responsible:
-
Gymnema Minor Buprenorphine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Buprenorphine interaction -
Yerba Mate Extract Minor Buprenorphine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Buprenorphine interaction -
Green Tea Minor Buprenorphine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Buprenorphine interaction
-
-
LevamlodipineConjupri Minor
The 3 ingredients responsible:
-
Green Tea Minor Levamlodipine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Levamlodipine interaction -
Gymnema Minor Levamlodipine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Levamlodipine interaction -
Yerba Mate Extract Minor Levamlodipine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Levamlodipine interaction
-
-
SunitinibSutent Minor
The 3 ingredients responsible:
-
Green Tea Minor Sunitinib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Sunitinib interaction -
Yerba Mate Extract Minor Sunitinib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Sunitinib interaction -
Gymnema Minor Sunitinib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Sunitinib interaction
-
-
IsradipineDynacirc CR Minor
The 3 ingredients responsible:
-
Green Tea Minor Isradipine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Isradipine interaction -
Gymnema Minor Isradipine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Isradipine interaction -
Yerba Mate Extract Minor Isradipine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Isradipine interaction
-
-
RegorafenibStivarga Minor
The 3 ingredients responsible:
-
Yerba Mate Extract Minor Regorafenib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Regorafenib interaction -
Gymnema Minor Regorafenib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Regorafenib interaction -
Green Tea Minor Regorafenib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Regorafenib interaction
-
-
DuvelisibCopiktra Minor
The 3 ingredients responsible:
-
Gymnema Minor Duvelisib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Duvelisib interaction -
Yerba Mate Extract Minor Duvelisib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Duvelisib interaction -
Green Tea Minor Duvelisib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Duvelisib interaction
-
-
Trimetrexate GlucuronateNeutrexin Minor
The 3 ingredients responsible:
-
Green Tea Minor Trimetrexate Glucuronate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Trimetrexate Glucuronate interaction -
Gymnema Minor Trimetrexate Glucuronate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Trimetrexate Glucuronate interaction -
Yerba Mate Extract Minor Trimetrexate Glucuronate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Trimetrexate Glucuronate interaction
-
-
DesogestrelCerazette Minor
The 3 ingredients responsible:
-
Yerba Mate Extract Minor Desogestrel is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Desogestrel interaction -
Gymnema Minor Desogestrel is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Desogestrel interaction -
Green Tea Minor Desogestrel is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Desogestrel interaction
-
-
EncorafenibBraftovi Minor
The 3 ingredients responsible:
-
Gymnema Minor Encorafenib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Encorafenib interaction -
Yerba Mate Extract Minor Encorafenib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Encorafenib interaction -
Green Tea Minor Encorafenib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Encorafenib interaction
-
-
BepridilVascor Minor
The 3 ingredients responsible:
-
Gymnema Minor Bepridil is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Bepridil interaction -
Yerba Mate Extract Minor Bepridil is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Bepridil interaction -
Green Tea Minor Bepridil is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Bepridil interaction
-
-
Ergotamine Tartrate (prescription Drug)Ergomar Sublingual, Ergostat SL Minor
The 3 ingredients responsible:
-
Green Tea Minor Ergotamine Tartrate (prescription Drug) is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Ergotamine Tartrate (prescription Drug) interaction -
Gymnema Minor Ergotamine Tartrate (prescription Drug) is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Ergotamine Tartrate (prescription Drug) interaction -
Yerba Mate Extract Minor Ergotamine Tartrate (prescription Drug) is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Ergotamine Tartrate (prescription Drug) interaction
-
-
LarotrectinibVitrakvi Minor
The 3 ingredients responsible:
-
Green Tea Minor Larotrectinib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Larotrectinib interaction -
Gymnema Minor Larotrectinib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Larotrectinib interaction -
Yerba Mate Extract Minor Larotrectinib is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Larotrectinib interaction
-
-
Cobimetinib FumarateCotellic Minor
The 3 ingredients responsible:
-
Green Tea Minor Cobimetinib Fumarate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Cobimetinib Fumarate interaction -
Yerba Mate Extract Minor Cobimetinib Fumarate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Cobimetinib Fumarate interaction -
Gymnema Minor Cobimetinib Fumarate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Cobimetinib Fumarate interaction
-
-
FlibanserinAddyi Minor
The 3 ingredients responsible:
-
Yerba Mate Extract Minor Flibanserin is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Flibanserin interaction -
Gymnema Minor Flibanserin is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Flibanserin interaction -
Green Tea Minor Flibanserin is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Flibanserin interaction
-
-
LumateperoneCaplyta Minor
The 3 ingredients responsible:
-
Green Tea Minor Lumateperone is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Lumateperone interaction -
Yerba Mate Extract Minor Lumateperone is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Lumateperone interaction -
Gymnema Minor Lumateperone is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Lumateperone interaction
-
-
Rabeprazole SodiumAciphex, Aciphex Sprinkle Minor
The 3 ingredients responsible:
-
Green Tea Minor Rabeprazole Sodium is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Rabeprazole Sodium interaction -
Gymnema Minor Rabeprazole Sodium is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Rabeprazole Sodium interaction -
Yerba Mate Extract Minor Rabeprazole Sodium is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Rabeprazole Sodium interaction
-
-
PanobinostatFarydak Minor
The 3 ingredients responsible:
-
Yerba Mate Extract Minor Panobinostat is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Panobinostat interaction -
Green Tea Minor Panobinostat is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Panobinostat interaction -
Gymnema Minor Panobinostat is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Panobinostat interaction
-
-
Esomeprazole StrontiumEsomeprazole Strontium Minor
The 3 ingredients responsible:
-
Gymnema Minor Esomeprazole Strontium is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, gymnema might increase levels of drugs metabolized by CYP3A4.
The full Gymnema + Esomeprazole Strontium interaction -
Yerba Mate Extract Minor Esomeprazole Strontium is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate Extract + Esomeprazole Strontium interaction -
Green Tea Minor Esomeprazole Strontium is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea + Esomeprazole Strontium interaction
-
Does It Work? Stacker 2 Capsules
How it rates in the research so far, then each ingredient on its own. A grade is the research so far, never an endorsement.
What It Is Marketed For
Fat burning and weight loss support
From the claims on the product’s label.
Closest match for what it is marketed for
Caffeine for obesity
Some studies support it, but the evidence isn’t conclusive.
Our pharmacy team’s notes on this supplement
- For gymnema and yerba mate extract, the evidence is not established.
- Every rating for gymnema (diabetes, obesity, prediabetes, and metabolic syndrome) and for yerba mate (arrhythmia, athletic performance, osteoporosis, chronic fatigue syndrome, headache, and cognitive function) is Insufficient Reliable Evidence To Rate.
- We have no effectiveness ratings for the other ingredients.
The Evidence, Ingredient by Ingredient
Each card holds our notes on one ingredient, then its uses graded effective, likely effective or possibly effective.
Cola Nut
From our Cola Nut guide
- People use cola nut mainly to boost energy, stay alert, and fight tiredness.
- It is also marketed for mental focus, physical performance, and weight loss.
No use is graded effective, likely effective or possibly effective for it yet.
Every graded use, in the Cola Nut guideYerba Mate
From our Yerba Mate guide
- Yerba mate is most reliably useful as a source of caffeine, which can increase alertness and reduce feelings of tiredness.
- This stimulant effect is well known and is the main reason most people drink it.
No use is graded effective, likely effective or possibly effective for it yet.
Every graded use, in the Yerba Mate guideCaffeine
Our pharmacy team’s notes on Caffeine
- These ratings come from caffeine's own entry.
Research suggests a benefit for
- Athletic performance and mental alertness
- Obesity (the use on its label), diabetes, memory and postdural puncture headache
Not counted here: one graded use is for Caffeine injected or put on the skin (bronchopulmonary dysplasia), not for a product like this one. Two more are for conditions treated by a doctor or in a hospital (neonatal apnea and postoperative headache).
Every graded use, in the Caffeine guideGreen Tea
From our Green Tea guide
- People use green tea for a wide range of reasons, but the strength of the evidence varies a lot depending on the use.
Research suggests a benefit for
- Hyperlipidemia and cardiovascular disease (CVD)
Not counted here: one graded use is for Green Tea injected or put on the skin (human papillomavirus (HPV)), not for a product like this one. Two more are for conditions treated by a doctor or in a hospital (endometrial cancer and ovarian cancer).
Every graded use, in the Green Tea guideGymnema
From our Gymnema guide
- People most often take gymnema to help support healthy blood sugar, including in type 2 diabetes.
- Some small human studies suggest it may modestly lower blood sugar and HbA1c when used alongside standard care, but the studies are often small, short, and of mixed quality.
No use is graded effective, likely effective or possibly effective for it yet.
Every graded use, in the Gymnema guideThe grades are the Natural Medicines database’s, which we license; tap a grade for what it means. They are about each ingredient, not this exact product.
About Stacker 2
Manufacturer and brand details for Stacker 2 Capsules, from the product label.
Stacker 2 has 7 products in our supplement database, all of them on the market, with labels on file since 2012. Our database is built from the NIH’s Dietary Supplement Label Database and our pharmacy team’s own additions, so it covers the labels filed there, not every product the brand sells.
- Name
- NVE Pharmaceuticals
- City
- Andover
- State
- NJ
- ZipCode
- 07821
- Phone Number
- 1-800-LITE-LINE
- Web Address
- WWW.STACKER2.COM
Stacker 2 Capsules: Common Questions
Does Stacker 2 Capsules interact with any drugs?
What are the side effects of Stacker 2 Capsules?
Who should be careful taking Stacker 2 Capsules?
Can Stacker 2 Capsules affect the liver?
Can Stacker 2 Capsules affect the kidneys?
How can Stacker 2 Capsules interact with so many drugs?
Where does the information about Stacker 2 Capsules come from?
Does Stacker 2 actually improve mental alertness?
Is Stacker 2 okay during pregnancy?
What is gymnema used for?
Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy
Still Have a Question About Stacker 2 Capsules?
Our pharmacists answer drug and supplement questions, free, by email.
Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and drugs.
Who Reviews This Page
The pharmacist behind it, and how it is checked.
Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist and founder of HelloPharmacist
A licensed pharmacist for more than 13 years, he built the system behind this page: it reads the label on file, matches each active ingredient to its record in the Natural Medicines database, checks those records against every drug we cover, and our pharmacy team writes the take and the interaction summary from those records.
- 13+ Years in PharmacyRetail and clinical pharmacy, medication safety and healthcare administration.
- Board Certified (BCPS)A pharmacotherapy specialist, certified by the Board of Pharmacy Specialties.
- Herbalist TrainingCertificates in medical ethnobotany, for the herbs and supplements people take.
Where This Page Comes From
Stacker 2 Capsules’s label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.
- NIH Dietary Supplement Label Database (DSLD)
- The official product label on file for this supplement.
- Natural Medicines (Therapeutic Research Center)
- The evidence-graded clinical reference behind the ingredient interaction, evidence and safety records, which we license.
- HelloPharmacist Editorial Team
- Content is reviewed by the HelloPharmacist Editorial Team, the pharmacists on our staff and those we contract. See our data sources and editorial standards for how this information is built and checked.
- The Pharmacy Team’s Take and Summaries
- Generated from HelloPharmacist’s pharmacist-curated databases and editorial rules. Clinical methodology reviewed by Dr. Brian Staiger, PharmD, BCPS. Last generated Oct 30, 2026. How we use AI
- The ratings in the Quick Summary
- They summarize available label information, ingredient evidence and known drug-safety records: a summary of what is known, not a grade of the product itself. They do not verify product identity, purity, potency, contamination or manufacturing quality. How these ratings are computed
The References Behind the Interaction Records
Every citation the ingredients’ records rest on is listed in that ingredient’s guide, in context: Cola Nut, 157 references; Caffeine, 235 references; Yerba Mate, 124 references; Green Tea, 219 references; Gymnema, 12 references .
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Keep Exploring
- Supplement interaction checkerCheck any supplement or product against your drugs
- Drug–drug interactionsCheck two or more of your drugs against each other
- Browse drugs A to ZEvery drug we have checked against herbs and supplements
- NDC and pricing lookupFind a drug’s NDCs, packaging and costs
- Ask a pharmacistA free, personal answer from our licensed team